Early studies targeting specific genomic loci by extensive long-range mapping have established a handful of enhancers as causative in very specific disorders such as the beta-globin enhancers in Thalassemia’s [90, 91] and a RET enhancer in Hirschsprung disease [92, 93]. The gene discussed is RET; the disease is Hirschsprung disease.